Supportive care in hemato-oncology: a review in light of the latest guidelines
Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact...
Gespeichert in:
| Veröffentlicht in: | Turkish journal of haematology 2012-03, Vol.29 (1), p.1-9 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 9 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Turkish journal of haematology |
| container_volume | 29 |
| creator | Gündüz, Eren Gülbaş, Zafer |
| description | Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines. |
| doi_str_mv | 10.5505/tjh.2012.10327 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3986760</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1540128724</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-9b251ee92652eae0c0d5c22cc11b6e6bdeac7c3e2d649737a55a7b20254ddb3a3</originalsourceid><addsrcrecordid>eNpVkL1PwzAQxS0EoqWwMiKPLCn2ObYbBiRU8SVVMABz5DjXxlUSh8Qp6n9PgILgljvpnX5P7xFyytlUSiYvwrqYAuMw5UyA3iNjLtgskqDE_tfNIj3MiBx13ZoxmClgh2QEsY5jxfWYPD73TePb4DZIrWmRupoWWJngI19bX_rV9pIa2uLG4funWLpVEahf0lAgLU3ALtBV73IsXY3dMTlYmrLDk92ekNfbm5f5fbR4unuYXy-iBpQKUZKB5IgJKAlokFmWSwtgLeeZQpXlaKy2AiFXcaKFNlIanQEDGed5JoyYkKtvbtNnFeYW69CaMm1aV5l2m3rj0v9K7Yp05TepSGZKKzYAzneA1r_1Q4i0cp3FsjQ1-r5LuYyHVmca4uH17K_Xr8lPieIDQwt11w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1540128724</pqid></control><display><type>article</type><title>Supportive care in hemato-oncology: a review in light of the latest guidelines</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Gündüz, Eren ; Gülbaş, Zafer</creator><creatorcontrib>Gündüz, Eren ; Gülbaş, Zafer</creatorcontrib><description>Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines.</description><identifier>ISSN: 1300-7777</identifier><identifier>EISSN: 1308-5263</identifier><identifier>DOI: 10.5505/tjh.2012.10327</identifier><identifier>PMID: 24744617</identifier><language>eng</language><publisher>Turkey: Galenos Publishing</publisher><subject>Review</subject><ispartof>Turkish journal of haematology, 2012-03, Vol.29 (1), p.1-9</ispartof><rights>Turkish Journal of Hematology, Published by Galenos Publishing. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986760/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986760/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24744617$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gündüz, Eren</creatorcontrib><creatorcontrib>Gülbaş, Zafer</creatorcontrib><title>Supportive care in hemato-oncology: a review in light of the latest guidelines</title><title>Turkish journal of haematology</title><addtitle>Turk J Haematol</addtitle><description>Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines.</description><subject>Review</subject><issn>1300-7777</issn><issn>1308-5263</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNpVkL1PwzAQxS0EoqWwMiKPLCn2ObYbBiRU8SVVMABz5DjXxlUSh8Qp6n9PgILgljvpnX5P7xFyytlUSiYvwrqYAuMw5UyA3iNjLtgskqDE_tfNIj3MiBx13ZoxmClgh2QEsY5jxfWYPD73TePb4DZIrWmRupoWWJngI19bX_rV9pIa2uLG4funWLpVEahf0lAgLU3ALtBV73IsXY3dMTlYmrLDk92ekNfbm5f5fbR4unuYXy-iBpQKUZKB5IgJKAlokFmWSwtgLeeZQpXlaKy2AiFXcaKFNlIanQEDGed5JoyYkKtvbtNnFeYW69CaMm1aV5l2m3rj0v9K7Yp05TepSGZKKzYAzneA1r_1Q4i0cp3FsjQ1-r5LuYyHVmca4uH17K_Xr8lPieIDQwt11w</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Gündüz, Eren</creator><creator>Gülbaş, Zafer</creator><general>Galenos Publishing</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120301</creationdate><title>Supportive care in hemato-oncology: a review in light of the latest guidelines</title><author>Gündüz, Eren ; Gülbaş, Zafer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-9b251ee92652eae0c0d5c22cc11b6e6bdeac7c3e2d649737a55a7b20254ddb3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gündüz, Eren</creatorcontrib><creatorcontrib>Gülbaş, Zafer</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Turkish journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gündüz, Eren</au><au>Gülbaş, Zafer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Supportive care in hemato-oncology: a review in light of the latest guidelines</atitle><jtitle>Turkish journal of haematology</jtitle><addtitle>Turk J Haematol</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>29</volume><issue>1</issue><spage>1</spage><epage>9</epage><pages>1-9</pages><issn>1300-7777</issn><eissn>1308-5263</eissn><abstract>Recent developments in cancer therapy have resulted in increases in treatment success rates and survival. One of thebasic goals of such therapy is improving patient quality of life. Chemotherapy protocols for solid or hematologicalmalignancies-most of which include multiple agents-negatively impact patient quality of life. Additionally, there havebeen developments in supportive care, which seeks to ameliorate or minimize the negative effects of chemotherapy.Herein we present a review and brief summarization of some of the agents used for supportive care in cancer patientsin light of the latest guidelines.</abstract><cop>Turkey</cop><pub>Galenos Publishing</pub><pmid>24744617</pmid><doi>10.5505/tjh.2012.10327</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1300-7777 |
| ispartof | Turkish journal of haematology, 2012-03, Vol.29 (1), p.1-9 |
| issn | 1300-7777 1308-5263 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3986760 |
| source | DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
| subjects | Review |
| title | Supportive care in hemato-oncology: a review in light of the latest guidelines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T18%3A11%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Supportive%20care%20in%20hemato-oncology:%20a%20review%20in%20light%20of%20the%20latest%20guidelines&rft.jtitle=Turkish%20journal%20of%20haematology&rft.au=G%C3%BCnd%C3%BCz,%20Eren&rft.date=2012-03-01&rft.volume=29&rft.issue=1&rft.spage=1&rft.epage=9&rft.pages=1-9&rft.issn=1300-7777&rft.eissn=1308-5263&rft_id=info:doi/10.5505/tjh.2012.10327&rft_dat=%3Cproquest_pubme%3E1540128724%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1540128724&rft_id=info:pmid/24744617&rfr_iscdi=true |